Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme To Acquire Ilex Oncology

This article was originally published in The Pink Sheet Daily

Executive Summary

Genzyme will pay $1 bil. for its first oncology therapeutic agent through the acquisition of Ilex Oncology

You may also be interested in...



Genzyme/Bayer Get FDA Approval For Campath As First-Line Treatment In Lymphocytic Leukemia

Bayer, who markets the mAb, does not plan any expansion of its 90-strong U.S. sales force in light of the label extension, firm tells “The Pink Sheet” DAILY.

Genzyme/Bayer Get FDA Approval For Campath As First-Line Treatment In Lymphocytic Leukemia

Bayer, who markets the mAb, does not plan any expansion of its 90-strong U.S. sales force in light of the label extension, firm tells “The Pink Sheet” DAILY.

Genzyme Asks For Campath Label Expansion To First-Line Lymphocytic Leukemia

Data supporting the B-cell lymphocytic leukemia sBLA also completes Campath’s 2001 Phase IV obligation.

Related Content

Topics

UsernamePublicRestriction

Register

LL1135489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel